Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels

Molecular Genetics and Metabolism

Volumn 63, Issue 2, 1998, Pages 134-141

  Belfiore, Francesco ^a   Iannello, Silvia ^a   Volpicelli, Giovanni ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

FFA, NEFA; Free fatty acids; Glycemia; Insulin; Insulin resistance; Insulin sensitivity; OGTT; Oral glucose tolerance test

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN;

ARTICLE; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL VALUE; PRIORITY JOURNAL;

EID: 0031711610     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1997.2658     Document Type: Article

References (26)

1. Flier J.S. Lilly Lecture: Syndromes of insulin resistance. From patient to gene and back again. Diabetes 41:1207-1219, 1992.
2. Taylor SI. Lilly Lecture: Molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin receptor gene. Diabetes 41:1473-1490, 1992.
3. Muller-Wieland D, Streicher R, Siemeister G, Krone W. Molecular biology of insulin resistance. Exp Clin Endocrinol 101:17-29, 1993.
4. De Fronzo RA, Tobin J, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E273, 1979.
5. Alford FP, Martin FIR, Pearson MJ. The significance and interpretation of mildly abnormal oral glucose tolerance. Diabetologia 7:173-180, 1971.
6. Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, Corgnati A, Muggeo M. Estimates of in vivo insulin action in man: Comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 68:374-378, 1989.
7. Shen SW, Reaven GM, Farquhar JW. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 49:2151-2160, 1970.
8. Harano Y, Ohgaku S, Hidaka H, Haneda K, Kikkawa R, Shigeta Y, Abe H. Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. J Clin Endocrinol Metab 45:1124-1127, 1977.
9. Ratzman KP, Besch W, Witt S, Schulz B. Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance. Diabetologia 21:192-197, 1981.
10. Bergman RN, Phillips SL, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: Measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68: 1456-1467, 1981.
11. Bergman RN. Toward physiological understanding of glucose tolerance: Minimal-model approach (Lilly Lecture). Diabetes 38:1512-1527, 1989.
12. Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Darling P, Bown EG, Turner RC. Continuous infusion of glucose with model assessment: Measurement of insulin resistance and β-cell function in man. Diabetologia 28:401-411, 1985.
13. WHO Expert Committee on Diabetes Mellitus. Second Report. Technical Report Series 646, 1980.
14. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979.
15. Bonora E, Zavaroni I, Alpi O, Pezzarossa A, Bruschi F, Guerra L, Dall'Aglio E, Coscelli C, Butturini U. Insulin and C-peptide responses to 75 g oral glucose load in the healthy man. Diabetes Metab 12:143-148, 1986.
16. Zavaroni I, Dall'Aglio E, Bruschi F, Bonora E, Alpi O, Pezzarossa A, Butturini U. Effect of age and environmental factors on glucose tolerance and insulin secretion in a worker population. J Am Geriatr Soc 34:271-275, 1986.
17. Reaven GM, Brand RJ, Chen Y-DI, Mathur AK, Goldfine I. Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals. Diabetes 42:1324-1332, 1993.
18. Reaven GM, Hollenbeck C, Chen Y-DI. Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32:52-55, 1989.
19. Gelding SV, Niththyananthan R, Chan S-P, Skinner E, Robinson S, Gray IP, Mather H, Johnston DG. Insulin sensitivity in non-diabetic relatives of patients with non-insulindependent diabetes from two ethnic groups. Clin Endocrinol 40:55-62, 1994.
20. Filipovsky J, Ducimetiere P, Eschwege E, Richard JL, Rosselin G, Claude JR. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J Hypertens 14:229-235, 1996.
21. Byrne CD, Wareham NJ, Day NE, McLeish R, Williams DR, Hales CN. Decreased non-esterified fatty acid suppression and features of the insulin resistance syndrome occur in a sub-group of individuals with normal glucose tolerance. Diabetologia 38:1358-1366, 1995.
22. Byrne CD, Wareham NJ, Brown DC, Clark PMS, Cox LJ, Day NE, Palmer CR, Wang TWM, Williams DRR, Hales CN. Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: Relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids. Diabetologia 37:889-896, 1994.
23. Laws A, Hoen HM, Selby JV, Saad MF, Haffner SM, Howard BV. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Arterioscler Thromb Vasc Biol 17:64-71, 1997.
24. Campbell PJ, Carlson MG, Hill JO, Nurjhan N. Regulation of free fatty acid metabolism by insulin in humans: Role of lipolysis and reesterification. Am J Physiol 263: E1063-E1069, 1992.
25. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993.
26. Reaven GM, Moore J, Greenfield M. Quantification of insulin secretion and in vivo insulin action in nonobese and moderately obese individuals with normal glucose tolerance. Diabetes 32:600-604, 1983.